Recovery Stack (IGF-1 LR3 + BPC-157 + TB-500)
This Recovery stack combines IGF-1 LR3, BPC-157, and TB-500 for tissue repair, recovery support, and muscle regeneration research. The peptide names are included in the title to separate this version from Wolverine and other regeneration-focused stacks.
Recovery Stack Quick Overview
IGF-1 LR3
Muscle recovery and anabolic signaling
30–50 mcg daily
BPC-157
Local tissue repair
250–500 mcg daily
TB-500
Systemic healing
2–5 mg weekly
What Is the Recovery Stack
This stack combines one recovery-focused growth factor analog with two well-known repair-oriented peptides. IGF-1 LR3 is typically discussed for muscle growth and recovery signaling, while BPC-157 is commonly used in localized repair conversations and TB-500 in systemic healing contexts.
Compared with a simpler recovery stack, this version is aimed at people who want repair plus a stronger muscle-regeneration angle. That is why the name includes the exact components rather than using a generic title alone.
How the Stack Works
IGF-1 LR3
Muscle signaling — is discussed for anabolic and regenerative support
Post-workout use — is often paired with training recovery goals
Recovery support — may help frame this stack beyond soft-tissue repair alone
BPC-157
Localized repair — is often used for tendon, ligament, and injury-site support
Collagen-related interest — may support soft-tissue remodeling
Daily structure — is commonly the local-repair backbone of recovery protocols
TB-500
Systemic repair — supports broader recovery rather than one specific site
Cell migration — is commonly discussed in tissue-remodeling contexts
Mobility support — often paired with healing and return-to-training goals
The stack combines local repair, systemic healing, and muscle-regeneration signaling. That makes it a broader recovery concept than BPC-157 or TB-500 alone.
Benefits
Enhanced recovery and tissue repair support
Muscle-regeneration positioning
Soft-tissue and connective-tissue coverage
Broader support than a two-peptide repair stack
Recovery planning for training or injury cycles
Typical Protocol
1–6
7–8
Optional taper
Optional maintenance
A common pattern is 6–8 weeks, with IGF-1 LR3 usually treated as the shortest-duration component. See the BPC-157 protocol and TB-500 healing-time guide for more context.
Recovery Timeline
Week 1–2: Inflammation, soreness, and training-readiness are early checkpoints
Week 3–4: Mobility, tissue tolerance, and recovery speed become more visible
Week 5–8: Structural repair and muscle-regeneration goals are typically assessed over the longer window
Timelines depend on injury type, workload, sleep, and nutrition. For individual components, see BPC-157 how long to work and TB-500 healing time.
Stack Calculator
Build this stack in the PeptideUniv Planner →
Related Stacks
Wolverine stack
Growth hormone stack
Fat loss peptide stack
FAQs
This Recovery stack combines IGF-1 LR3, BPC-157, and TB-500. The page title includes the exact ingredients so it stays distinct from other recovery-oriented stacks like Wolverine or more advanced regeneration protocols.
Wolverine focuses on BPC-157 and TB-500. This Recovery stack adds IGF-1 LR3, which shifts it toward recovery plus muscle-regeneration and anabolic signaling discussion.
People usually look at this type of stack for injury recovery, soft-tissue support, post-training repair, and preserving or rebuilding muscle while healing.
A common range is 6–8 weeks, though timing varies by injury severity, training load, and which compounds are emphasized most strongly.
No. The full three-part stack is not backed by strong direct human trial data. Most discussion is extrapolated from individual compound literature and practice-based stacking logic.
Sources
The therapeutic potential of IGF-I in skeletal muscle repair (PubMed)
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth (PubMed)
Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation (PubMed)
The actin binding site on thymosin beta4 promotes angiogenesis (PubMed)
The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients (PubMed)
Related tools
Open calculator at PeptideUniv → · Build stacks in the Planner →
Internal linking
Related Peptides
BPC-157
TB-500
Related Protocols
BPC-157 protocol
TB-500 protocol
Related Calculators
BPC-157 dosage calculator
TB-500 dosage calculator
Related Stacks
For educational and research purposes only. Not medical advice. Consult a licensed healthcare professional for personal guidance.